title: Electrospun aligned nanofibrous composite of MWCNT/polyurethane to enhance vascular endothelium cells proliferation and function.
abstract: Aligned or random nanofibrous meshes of multiwalled carbon nanotubes/polyurethane composite (MWCNT/PU) were fabricated by electrospinning and characterized by scanning electron microscopy (SEM). The regulatory effects of nanofibrous structure and MWCNT on the growth and anticoagulant function of human umbilical vein endothelial cells (HUVECs) were investigated by examining proliferation, type IV collagen secretion, tissue factor and plasminogen activator inhibitor-1 (PAI-1) release, and cytoskeleton arrangement, as well as via pull-down analysis. We show that aligned nanofibrous structure and MWCNT can function as extracellular signals to stimulate cell growth, proliferation, and extracellular collagen secretion, in addition to preserving anticoagulant function. The nanofibrous structures played important roles in the activation of Rac and Cdc42, while CNT regulated the activation of Rho. These two features synergistically activated Rho GTPases that transmitted cell-substrate signals to the cytoplasm. These signals were then relayed to the nucleus by the MAP kinase pathway to direct cytoskeletal arrangement and cell orientation.
authors.affiliation: Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China.
authors.forename: Jie
authors.initials: J
authors.lastname: Meng
authors.forename: Zhaozhao
authors.initials: Z
authors.lastname: Han
authors.forename: Hua
authors.initials: H
authors.lastname: Kong
authors.forename: Xiaojin
authors.initials: X
authors.lastname: Qi
authors.forename: Chaoying
authors.initials: C
authors.lastname: Wang
authors.forename: Sishen
authors.initials: S
authors.lastname: Xie
authors.forename: Haiyan
authors.initials: H
authors.lastname: Xu
mesh_terms: D000925:Anticoagulants / Q000378:metabolism; D049109:Cell Proliferation / Q000187:drug effects; D048430:Cell Shape / Q000187:drug effects; D024141:Collagen Type IV / Q000378:metabolism; D003599:Cytoskeleton / Q000187:drug effects / Q000378:metabolism; D042783:Endothelial Cells / Q000166:cytology* / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D004789:Enzyme Activation / Q000187:drug effects; D006801:Humans; D007797:Laminin / Q000378:metabolism; D057139:Nanofibers / Q000737:chemistry* / Q000648:ultrastructure; D037742:Nanotubes, Carbon / Q000737:chemistry* / Q000648:ultrastructure; D017395:Plasminogen Activator Inhibitor 1 / Q000378:metabolism; D011140:Polyurethanes / Q000494:pharmacology*; D013925:Thromboplastin / Q000378:metabolism; D023822:Tissue Engineering / Q000379:methods*; D054457:Tissue Scaffolds / Q000737:chemistry*; D020764:cdc42 GTP-Binding Protein / Q000378:metabolism; D020741:rho GTP-Binding Proteins / Q000378:metabolism
chemical_list: D000925:Anticoagulants; D024141:Collagen Type IV; D007797:Laminin; D037742:Nanotubes, Carbon; D017395:Plasminogen Activator Inhibitor 1; D011140:Polyurethanes; D013925:Thromboplastin; D020764:cdc42 GTP-Binding Protein; D020741:rho GTP-Binding Proteins